맞춤형 의료 바이오마커 시장 : 적응증별, 용도별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

REPORT HIGHLIGHT

Personalized Medicine Biomarkers Market size was valued at USD 14,908.34 million in 2023, expanding at a CAGR of 14.30% from 2024 to 2032.

Personalized medicine, involving the use of biomarkers in clinical samples, is a fascinating field with important implications for drug development. Biomarkers act as measurable indicators of a biological state or condition, allowing for the prediction of disease risk, diagnosis of conditions, monitoring of disease progression, and guidance of treatment decisions. They are essential in personalized medicine, offering possibilities to improve patient outcomes through precise and individualized healthcare. Continuous progress in biomarker research and technology is driving the field ahead, leading to a future where treatments are tailored more and more to each patient's unique traits.

Personalized Medicine Biomarkers Market- Market Dynamics

The market is anticipated to experience growth due to the rising prevalence of chronic diseases and the increasing recognition of the significance of prognostic prediction

Chronic illnesses, such as cancer, cardiovascular diseases, diabetes, and neurodegenerative disorders, are increasing on a global scale. Tailored medicine provides precise and efficient treatment options for these ailments, often utilizing biomarkers to customize therapies for individual patients. According to the U.S. National Center for Health Statistics, a chronic illness is a condition that persists for three months or longer. Approximately 40 million Americans face limitations in their daily activities due to one or more chronic health issues. Prognostic biomarkers aid in forecasting disease outcomes, facilitating more informed decision-making in clinical settings. Moreover, the heightened investment in personalized medicine research by both governmental and private sectors supports the advancement of new biomarkers and diagnostic tools, creating growth opportunities for the market. Nevertheless, challenges related to regulations and reimbursement may impede the market's expansion.

Personalized Medicine Biomarkers Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.30% over the forecast period (2024-2032)

Based on Indication segmentation, Oncology was predicted to show maximum market share in the year 2023

Based on application segmentation, Early Detection/Screening was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Personalized Medicine Biomarkers Market- Segmentation Analysis:

The Global Personalized Medicine Biomarkers Market is segmented based on Indication, Application, End-User, and Region.

The market is categorized into three segments based on Indication: Neurology, Oncology, Diabetes, Cardiology, Autoimmune Diseases, and Others. The market is primarily dominated by the Oncology segment. The personalized medicine biomarkers market, particularly in the field of oncology, is witnessing substantial growth owing to technological advancements and a rising need for customized treatment methods.

The market is categorized into two segments according to their application: Diagnosis, Treatment Selection, Early Detection/Screening, and Monitoring. The dominant segment in the market is Early Detection/Screening. The significance of early detection and screening biomarkers cannot be overstated as they facilitate the identification of diseases at an earlier and more manageable stage, leading to better patient outcomes and decreased healthcare expenses.

The market is segmented into two distinct categories based on the end-user: hospitals and clinics, and other entities. Hospitals, clinics, and diagnostic laboratories will remain crucial end-users, utilizing biomarkers to improve diagnostic precision and treatment effectiveness.

Personalized Medicine Biomarkers Market- Geographical Insights

Geographically, this market spans across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further segmented by countries contributing to business activities. The market is predominantly led by North America, driven by the increasing demand for personalized medicine. There is a notable focus on personalized medicine in North America, spurred by the necessity for more efficient and customized treatment options. Personalized medicine strives to individualize healthcare, tailoring medical decisions and treatments to each patient. As per the American Journal of Managed Care, there has been significant growth overall from 2016 to 2020, with the number of personalized medicines in the market increasing from 132 to 286. These medicines represented 25% of the new drugs approved by the FDA in 2019. Europe follows as the second largest region for market growth, attributed to the rising adoption of Companion Diagnostics.

Personalized Medicine Biomarkers Market- Competitive Landscape:

The competitive landscape of the personalized medicine biomarkers market is characterized by fierce competition among various key players. These companies are making significant investments in research and development to discover new biomarkers and create advanced diagnostic tests. This constant innovation is crucial to stay ahead in the market. The market is being driven forward by rapid advancements in genomics, proteomics, and bioinformatics. Companies that effectively utilize these technologies can gain a competitive edge. In this highly competitive market, major players are striving to innovate and expand their capabilities through strategic initiatives. Continuous technological advancements, strategic collaborations, and a focus on obtaining regulatory approvals are vital for companies to maintain and strengthen their positions in the market.

Recent Developments:

On Monday, February 12, 2024, Abbott and Fujirebio announced their partnership to collaborate on the development of a research-use-only test for the neurofilament-light chain (NfL). In a joint statement, the companies revealed that this neurology biomarker assay will be compatible with Abbott's Alinity I instrument and will be made accessible to researchers engaged in studies that demonstrate the effectiveness of the NfL biomarker. The objective is to make this test commercially available by 2025, marking it as the inaugural RUO assay for the Alinity I system.

Biocartis, a Mechelen-based company in Belgium, has recently revealed an expanded alliance with Merck Serono Middle East and Merck Saudi Ltd., both subsidiaries of Merck KGaA, in the MEA region. The main aim of this partnership is to improve the accessibility of RAS biomarker testing for patients in the Middle East and North Africa.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Siemens Healthineers

F. Hoffmann-La Roche Ltd

Abbott Laboratories

Nexus-DX

Qiagen

PerkinElmer Inc.

Lifesign LLC

Merck & Co Inc.

Bio-Rad Laboratories, Inc.

EKF Diagnostics Holdings plc

Singulex Inc.

Signosis Inc.

BioSims Technologies

Agilent Technologies, Inc.

Thermo Fisher Scientific, Inc.

Illumina Inc.

Myriad Genetics, Inc.

Biomarker Technologies, Inc.

Danaher Corporation

Epigenomics AG

Others

GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

• Oncology
• Neurology
• Diabetes
• Autoimmune Diseases
• Cardiology
• Others

GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

• Early Detection/Screening
• Diagnosis
• Treatment Selection
• Monitoring

GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

• Hospitals and clinics
• Others

GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Personalized Medicine Biomarkers Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Personalized Medicine Biomarkers Market Snippet by Indication
  • 2.1.2. Personalized Medicine Biomarkers Market Snippet by Application
  • 2.1.3. Personalized Medicine Biomarkers Market Snippet by End-User
  • 2.1.4. Personalized Medicine Biomarkers Market Snippet by Country
  • 2.1.5. Personalized Medicine Biomarkers Market Snippet by Region
• 2.2. Competitive Insights

3. Personalized Medicine Biomarkers Key Market Trends

• 3.1. Personalized Medicine Biomarkers Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Personalized Medicine Biomarkers Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Personalized Medicine Biomarkers Market Opportunities
• 3.4. Personalized Medicine Biomarkers Market Future Trends

4. Personalized Medicine Biomarkers Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Personalized Medicine Biomarkers Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Personalized Medicine Biomarkers Market Landscape

• 6.1. Personalized Medicine Biomarkers Market Share Analysis, 2023
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Personalized Medicine Biomarkers Market - By Indication

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
  • 7.1.2. Oncology
  • 7.1.3. Neurology
  • 7.1.4. Diabetes
  • 7.1.5. Autoimmune Diseases
  • 7.1.6. Cardiology
  • 7.1.7. Others

8. Personalized Medicine Biomarkers Market - By Application

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
  • 8.1.2. Early Detection/Screening
  • 8.1.3. Diagnosis
  • 8.1.4. Treatment Selection
  • 8.1.5. Monitoring

9. Personalized Medicine Biomarkers Market - By End-User

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
  • 9.1.2. Hospitals and clinics
  • 9.1.3. Others

10. Personalized Medicine Biomarkers Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Personalized Medicine Biomarkers Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Personalized Medicine Biomarkers Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.8. Italy
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.8.3. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.9. United Kingdom
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.9.3. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.10. France
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.10.3. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.11. Russia
    • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.11.2. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.12. Netherlands
    • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.12.2. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.13.2. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.14. Poland
    • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.14.2. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.15. Rest of Europe
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Personalized Medicine Biomarkers Key Manufacturers in Asia Pacific
  • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.4.4. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.7. India
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.7.3. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.8. China
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.8.3. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.12. Thailand
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.12.3. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.13. Indonesia
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.13.3. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
• 10.5. Latin America
  • 10.5.1. Overview
  • 10.5.2. Personalized Medicine Biomarkers Key Manufacturers in Latin America
  • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.5.4. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
• 10.6. Middle East and Africa
  • 10.6.1. Overview
  • 10.6.2. Personalized Medicine Biomarkers Key Manufacturers in Middle East and Africa
  • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.6.4. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.8. United Arab Emirates
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Personalized Medicine Biomarkers Industry

• 11.1. Competitive Dashboard
• 11.2. Company Profiles
  • 11.2.1. Siemens Healthineers
  • 11.2.2. F. Hoffmann-La Roche Ltd
  • 11.2.3. Abbott Laboratories
  • 11.2.4. Nexus-DX
  • 11.2.5. Qiagen
  • 11.2.6. PerkinElmer Inc.
  • 11.2.7. Lifesign LLC
  • 11.2.8. Merck & Co Inc.
  • 11.2.9. Bio-Rad Laboratories, Inc.
  • 11.2.10. EKF Diagnostics Holdings plc
  • 11.2.11. Singulex Inc.
  • 11.2.12. Signosis Inc.
  • 11.2.13. BioSims Technologies
  • 11.2.14. Agilent Technologies, Inc.
  • 11.2.15. Thermo Fisher Scientific, Inc.
  • 11.2.16. Illumina Inc.
  • 11.2.17. Myriad Genetics, Inc.
  • 11.2.18. Biomarker Technologies, Inc.
  • 11.2.19. Danaher Corporation
  • 11.2.20. Epigenomics AG
  • 11.2.21. Others

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us